Literature DB >> 20650264

The tumor suppressor Rb and its related Rbl2 genes are regulated by Utx histone demethylase.

Minoru Terashima1, Akihiko Ishimura, Masakazu Yoshida, Yutaka Suzuki, Sumio Sugano, Takeshi Suzuki.   

Abstract

Utx is a candidate tumor suppressor gene that encodes histone H3 lysine 27 (H3K27) demethylase. In this study, we found that ectopic expression of Utx enhanced the expression of retinoblastoma tumor suppressor gene Rb and its related gene Rbl2. This activation was dependent on the demethylase activity of Utx, and was suggested to contribute to the decreased cell proliferation induced by Utx. A chromatin immunoprecipitation assay showed that over-expressed Utx was associated with the promoter regions of Rb and Rbl2 resulting in the removal of repressive H3K27 tri-methylation and the increase in active H3K4 tri-methylation. Furthermore, siRNA-mediated knockdown of Utx revealed the recruitment of endogenous Utx protein on the promoters of Rb and Rbl2 genes. These results indicate that Rb and Rbl2 are downstream target genes of Utx and may play important roles in Utx-mediated cell growth control. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20650264     DOI: 10.1016/j.bbrc.2010.07.061

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family.

Authors:  Zanabazar Enkhbaatar; Minoru Terashima; Dulamsuren Oktyabri; Shoichiro Tange; Akihiko Ishimura; Seiji Yano; Takeshi Suzuki
Journal:  Cell Cycle       Date:  2013-06-06       Impact factor: 4.534

2.  Tetrahymena thermophila JMJD3 homolog regulates H3K27 methylation and nuclear differentiation.

Authors:  Pei-Han Chung; Meng-Chao Yao
Journal:  Eukaryot Cell       Date:  2012-03-16

3.  Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.

Authors:  Naoimh Herlihy; Mehmet Dogrusöz; T Huibertus van Essen; J William Harbour; Pieter A van der Velden; Marja C J A van Eggermond; Geert W Haasnoot; Peter J van den Elsen; Martine J Jager
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-15       Impact factor: 4.799

4.  Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression.

Authors:  Lukas D Wartman; David E Larson; Zhifu Xiang; Li Ding; Ken Chen; Ling Lin; Patrick Cahan; Jeffery M Klco; John S Welch; Cheng Li; Jacqueline E Payton; Geoffrey L Uy; Nobish Varghese; Rhonda E Ries; Mieke Hoock; Daniel C Koboldt; Michael D McLellan; Heather Schmidt; Robert S Fulton; Rachel M Abbott; Lisa Cook; Sean D McGrath; Xian Fan; Adam F Dukes; Tammi Vickery; Joelle Kalicki; Tamara L Lamprecht; Timothy A Graubert; Michael H Tomasson; Elaine R Mardis; Richard K Wilson; Timothy J Ley
Journal:  J Clin Invest       Date:  2011-03-23       Impact factor: 14.808

5.  UTX inhibits EMT-induced breast CSC properties by epigenetic repression of EMT genes in cooperation with LSD1 and HDAC1.

Authors:  Hee-Joo Choi; Ji-Hye Park; Mikyung Park; Hee-Young Won; Hyeong-Seok Joo; Chang Hoon Lee; Jeong-Yeon Lee; Gu Kong
Journal:  EMBO Rep       Date:  2015-08-24       Impact factor: 8.807

6.  Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer.

Authors:  Michael L Nickerson; Garrett M Dancik; Kate M Im; Michael G Edwards; Sevilay Turan; Joseph Brown; Christina Ruiz-Rodriguez; Charles Owens; James C Costello; Guangwu Guo; Shirley X Tsang; Yingrui Li; Quan Zhou; Zhiming Cai; Lee E Moore; M Scott Lucia; Michael Dean; Dan Theodorescu
Journal:  Clin Cancer Res       Date:  2014-09-15       Impact factor: 12.531

7.  Expression and significance of histone H3K27 demethylases in renal cell carcinoma.

Authors:  Yongqing Shen; Xiaoqiang Guo; Yuejia Wang; Wei Qiu; Yanzhong Chang; Aili Zhang; Xianglin Duan
Journal:  BMC Cancer       Date:  2012-10-12       Impact factor: 4.430

8.  Female bias in Rhox6 and 9 regulation by the histone demethylase KDM6A.

Authors:  Joel B Berletch; Xinxian Deng; Di Kim Nguyen; Christine M Disteche
Journal:  PLoS Genet       Date:  2013-05-02       Impact factor: 5.917

Review 9.  What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer.

Authors:  Julie-Aurore Losman; William G Kaelin
Journal:  Genes Dev       Date:  2013-04-15       Impact factor: 12.890

10.  Epigenetic control and cancer: the potential of histone demethylases as therapeutic targets.

Authors:  Fernando Lizcano; Jeison Garcia
Journal:  Pharmaceuticals (Basel)       Date:  2012-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.